Related Articles
Dasatinib enhances antitumor activity of paclitaxel in ovarian cancer through Src signaling
Dual inhibition of MET and SRC kinase activity as a combined targeting strategy for colon cancer
Identification of biomarkers and their functions in dasatinib‑resistant pancreatic cancer using bioinformatics analysis
Growth inhibitory effect of the Src inhibitor dasatinib in combination with anticancer agents on uterine cervical adenocarcinoma cells
Antitumor activity of 7RH, a discoidin domain receptor 1 inhibitor, alone or in combination with dasatinib exhibits antitumor effects in nasopharyngeal carcinoma cells